A final rule of the Department of Safety and Professional Services, Controlled Substances Board, amends the Prescription Drug Monitoring Program (PDMP) effective September 1. The rule requires drug dosage units and the partial fill indicator to be submitted to the program and clarifies that health care professionals may access PDMP reports for scientific research purposes if the patient is a direct patient and gave informed consent.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.